Aunt Henrietta’s Birthday

August 28, 2014 @ 9:11 pm
posted by Dr Ginther

This weekend is Aunt Henrietta’s 90th birthday.  I have just the right gift for her, Adora Premium Chocolates.  My Aunt Henrietta has been our posterchild since the beginning of Cedar Valley Bone Health Institute of Iowa.  Her adventures are well chronicled.

First, she broke one wrist when she was thrown down by a throw rug.  Then she broke the other wrist when her bifocals did her in.  Then she broke her shoulder when she thought all the ice had melted.  I had to tell her Endocrinologist about the Anabolic, Forteo.  She agreed to give herself a daily shot.  Then she proved that treatment had worked by falling down the stairs and not breaking anything.  Finally she locked in the gains of Forteo by starting the Antiresorptive that gets along with her severe GERD and aging kidneys, Prolia.

She can live alone in her own home because she Took Control of her bone health, with Calcium, Vitamin D3, Protein, Multiple Vitamins and Minerals, and Osteoporosis Medications.  They are all necessary.

Happy Birthday Aunt Henrietta!

Jay Ginther, MD

Aromatase Inhibitors for Breast Cancer

August 24, 2014 @ 10:41 pm
posted by Dr Ginther

Aromatase Inhibitors (AI) do a great job treating Breast Cancers which are Estrogen dependent.  The AI wipe out all Estrogen thereby depriving the breast cancer of a needed stimulus.

Unfortunately, Aromatase Inhibitor treatment will also do considerable damage to your bones unless you take medication to protect your bones.  The good news is that we have medication which can completely offset the harm AI treatment could do to your bones.  But, you have to take it, and the sooner you start, the better.

Denosumab – Prolia – OPG Analog

August 21, 2014 @ 8:17 pm
posted by Dr Ginther

Denosumab (Prolia) mimics the natural process that keeps OsteoClasts (the cells that gobble up bone) under control before menopause.  OsteoCytes release Osteoprotegrin (OPG) when Estrogen (or Testosterone) is on board.  OPG controls the formation and activation of OsteoClasts by blocking RANK-Ligand, which is necessary for OsteoClast formation and activation.  This decreases fracture risk.